How to choose a GLP-1 provider: a 5-minute checklist

There are now hundreds of telehealth desks selling GLP-1 medication, and from the outside most of them look the same: a clean website, a low headline price, a promise to ship this week. The differences that actually matter are usually a click or two below the fold. This is the checklist we run before we score any provider on the Dose Brief ranking — you can run it yourself in about five minutes.

1. Is the price the price?

Start with the number, but don't stop there. The single most common trap in this market is the teaser rate: a low first-month price that steps up sharply once you're on the medication and least likely to switch. Before you sign up, find the ongoing monthly cost, not just the intro cost — and check whether there's a separate membership or consultation fee stacked on top. Those fees can be charged even when nothing is prescribed: Synergy Rx bills an $80 telehealth visit whether or not you receive medication, and that figure appears in none of its advertised prices — so a reader who is declined still pays. A desk that publishes one flat, all-in price you can plan around is worth more than a desk that leads with a cheaper number that doesn't hold. And check that there is a price to find at all: Oak advertises nine different "starting" figures at once and attaches a term to none of them, with its two cheapest appearing only beside a discount its own affiliate page describes as "$200 off 3-months" — none of the nine is the rate you would actually be billed — that is $200/mo for semaglutide and $250 for tirzepatide, published on the first screen of its order form. Three of its marketing pages also promise "Membership Fees: None" and "No subscriptions" while its own Terms say patients are charged a membership fee for a provider consult and that most prescriptions renew recurringly, which is the exact fine print this checklist exists to send you looking for. We dig into that dynamic in why GLP-1 prices move. If tirzepatide is the molecule you're after, our cheapest-tirzepatide tracker shows who's actually cheapest this cycle and flags which desks reach your state.

2. Is it a legitimate, accredited pharmacy?

Compounded GLP-1s are legal when they're made by a properly licensed 503A or 503B pharmacy, but the quality floor varies. Look for a LegitScript certification badge, a named pharmacy partner, and clear licensing information. If a site won't tell you who actually compounds and ships your medication, treat that as a yellow flag. Our companion guide, is compounded semaglutide legit?, walks through exactly what to check, and our compounded semaglutide supply page shows who's actually selling it and at what price right now. Most desks fail this one: of seven we read in August 2026, only two named a pharmacy at all, and Trellis Vitality was one of them — VialsRX, in Houston, disclosed in the site's own machine-readable file rather than buried. Note also that a certification badge is only as good as what it links to: Rehydra+ claims certification with a self-hosted image linking to a keyword search and publishes no seal identifier, which leaves the claim unverifiable rather than disproved.

3. Brand-name or compounded — and do you have a choice?

Some desks only sell compounded semaglutide or tirzepatide; others can also route you to FDA-approved brand-name products like Wegovy or Zepbound, sometimes with insurance navigation¹². Neither is automatically better, but they're different products with different price tags and supply pictures. If you have a strong preference — or insurance that might cover the brand — pick a desk that can actually offer it. The trade-offs are laid out in compounded vs brand-name GLP-1, explained.

4. Will it ship to your state, reliably?

Telehealth prescribing is regulated state by state, and not every provider serves every state. Confirm your state is on the list before you get attached to a price. While you're there, look for signals of a stable supply chain — a provider that names its sourcing and hasn't had public supply interruptions is a safer bet than one that's silent about it. Supply is a live issue in this category; see GLP-1 shortages and supply for the current picture.

5. Read the medical fine print

GLP-1 medications carry a boxed warning about thyroid C-cell tumors seen in rodent studies, and they're contraindicated for people with a personal or family history of medullary thyroid carcinoma or MEN 2¹² — see what that warning actually means in humans for the real-world evidence. A responsible provider also asks about GI history (relevant to the rare but real risk covered in GLP-1 lawsuits and gastroparesis: what the evidence shows), any personal or family history relevant to the NAION eye-safety signal, and any upcoming surgery or procedure — see GLP-1s before surgery for why that last one matters and should be flagged proactively, not left for you to bring up. A responsible provider screens for this and puts a real clinician between you and the prescription. If the intake feels like a formality — no meaningful health questions, no clinician contact — that's a reason to slow down and ask more.

6. Can you leave?

Finally, check the exit. How hard is it to cancel? Is there a lock-in, a coaching subscription you can't unbundle, or an auto-renew that's easy to miss? The best desks make leaving as easy as joining, because they're confident you'll stay for the right reasons.

Put it together

Run those six checks and most providers sort themselves quickly. If you'd rather start from a shortlist, our provider briefs score every desk we track on price stability, supply reliability, transparency, access, clinical oversight, and track record — the six factors behind the Brief Score. You can also put any two side by side on our compare pages. None of this is medical advice; it's a way to ask sharper questions before you talk to a clinician.